Supreme Court Scrutinizes FDA's Abortion Pill Approval Amid Safety Debate
March 26, 2024The US Supreme Court is assessing a case challenging the FDA's approval of the abortion pill Mifepristone.
Anti-abortion groups and physicians claim Mifepristone is unsafe for women and girls.
The FDA defends its decision with two decades of safety data supporting the drug's use.
Supreme Court's considerations include the challengers' standing and the legitimacy of the FDA's approval process.
The upcoming decision in June could impact both abortion rights and pharmaceutical regulation in the US.
Summary based on 35 sources
Get a daily email with more World News stories
Sources
BBC News • Mar 26, 2024
Supreme Court to hear arguments in abortion pill caseThe New York Times • Mar 26, 2024
Supreme Court to Hear Arguments on Abortion Pill MifepristoneThe New York Times • Mar 26, 2024
What Is Mifepristone and How Is It Used?The New York Times • Mar 26, 2024
Here’s What’s at Stake in the Supreme Court’s Abortion Pill Case